The DOI matches its Crossref record; the references it cites are not checked yet.
Microenvironment plasticity confers cetuximab resistance
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Extrinsic alterations of tumours may appear during treatment with cetuximab and panitumumab [18].”
From Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies (2021) · cites this paper as [18]
In the citing paper
“Microenvironmental plasticity dramatically affected by EGFR inhibition is as powerful of a driver of drug resistance as genetic alterations [18] (Fig. 2).”
From Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies (2021) · cites this paper as [18]
In the citing paper
“Autophagy and cancer stem cells (CSCs) also contribute to resistance to EGFR target therapy [18, 137].”
From Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies (2021) · cites this paper as [18]
Citations
The citation lists haven’t been fetched yet
References 1 · Cited by 10
Metadata
- Authors
- Sidaway, P.
- Corresponding author
- Sidaway, Peter
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2019-07-19
- Volume
- 16
- Issue
- 9
- Pages
- 527-527
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2962707552
- Cited by
- 10
- References
- 1
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2021: 2 · 2020: 3
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Reviews Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Keywords
- cetuximab resistance, EGFR, colorectal cancer, anti-EGFR therapy, treatment resistance, transcriptomics, genomics
- MeSH terms
- Cetuximab, Humans, Colorectal Neoplasms, Drug Resistance, Neoplasm, Genomics, Tumor Microenvironment, Transcriptome, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microenvironment plasticity confers cetuximab resistance. https://app.cochat.ai/papers/10.1038/s41571-019-0259-4
- The paper
- Sidaway, P. (2019). Microenvironment plasticity confers cetuximab resistance. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-019-0259-4
